跳至主要内容
临床试验/NCT00823602
NCT00823602Unknown3 期

Comparison Between GnRH Agonist Long Protocol And GnRH Antagonist Protocol In Outcome Of The First Cycle ART

Yazd Research & Clinical Center for Infertility1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
2
试验地点
1
主要终点
pregnancy rate

研究概览

简要总结

Literature suggests that GnRH antagonists are comparatively more often used in cycles which have an unfavorable prior prognosis, and this protocol is an ideal one for poor responder patients. Up to now, however not enough prospectives have been published to prove any beneficial effect of antagonists on the first cycle assisted reproductive technique.

This prospective study will do to evaluate the efficacy of gonadotropin releasing hormone antagonist in comparison with the standard long protocol in the first cycle of ART.

The investigators will randomize 160 patients undergoing ART for the first time . Group 1 (n=80) was stimulate with a standard long protocol and group 2 (n=80) stimulated with GnRH antagonist and then result of ART compare in two group .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 35 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • first cycle of ART
  • age < 35 years
  • basal FSH < 10 IU/L

排除标准

  • previous IVF or ICSI, hyperprolactinemia, hyperthyroidism, hypothyroidism, uterine abnormality, severe endometriosis
  • only one ovary

研究组 & 干预措施

1

Experimental

GnRH antagonist "ganirelix" 0.25 mg fromm 6th ovarian stimulation

干预措施: ganirelix (Drug)

2

Active Comparator

GnRH agonist, suprefact, stimulation with a standard long protocol

干预措施: suprefact (Drug)

结局指标

主要结局

pregnancy rate

时间窗: 2weeks

次要结局

  • ovarian stimulation(10days)

研究者

发起方
Yazd Research & Clinical Center for Infertility
申办方类型
Other

研究点 (1)

Loading locations...

相似试验